Skip to main content

Table 2 Duration of injection site-related adverse events (combined and separately for injection site pain)

From: A pooled analysis of injection site-related adverse events in patients with schizophrenia treated with olanzapine long-acting injection

 

N

Mean

SD

Min.

25thPercentile

Med.

75thPercentile

Max.

All events

        

Duration of all occurrences, days

137

9.7

16.9

1

1

3

11

117

Duration of first occurrence, days

98

10.0

14.9

1

1

3

14

86

Injection site pain

        

Duration of all occurrences, days

68

3.6

5.0

1

1

1.5

3.5

32

Duration of first occurrence, days

48

4.4

5.7

1

1

2.5

4.5

32

  1. Abbreviations: Max maximum, Med median, Min minimum, SD standard deviation.
  2. Note: One data point was excluded because it was an extreme outlier. Durations are not known for 18 events.